Fischer Medical Ventures Limited (NSE:FISCHER)
 99.06
 -8.01 (-7.48%)
  Nov 4, 2025, 12:30 PM IST
Fischer Medical Ventures Market Cap
Fischer Medical Ventures has a market cap or net worth of 69.52 billion as of November 3, 2025. Its market cap has increased by 98.13% in one year.
Market Cap 
 69.52B
Enterprise Value 
 69.47B
Revenue 
 1.71B
Ranking 
 n/a
PE Ratio 
 348.72
Stock Price 
99.06
Market Cap Chart
Since June 8, 2005, Fischer Medical Ventures's market cap has increased from 49.88M to 69.52B, an increase of 139,276.22%. That is a compound annual growth rate of 42.55%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Nov 3, 2025 | 69.52B | 84.57% | 
| Dec 31, 2024 | 37.67B | 6,473.59% | 
| Dec 29, 2023 | 573.00M | 3,239.74% | 
| Dec 30, 2022 | 17.16M | 6.06% | 
| Dec 31, 2021 | 16.18M | 167.19% | 
| Dec 31, 2020 | 6.05M | -40.89% | 
| Dec 10, 2019 | Upgrade Pro | Upgrade Pro | 
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro | 
| Dec 29, 2015 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Sun Pharmaceutical Industries | 4.06T | 
| Divi's Laboratories | 1.79T | 
| Cipla | 1.21T | 
| Apollo Hospitals Enterprise | 1.10T | 
| Mankind Pharma | 984.02B | 
| Zydus Lifesciences | 980.52B | 
| Fortis Healthcare | 772.36B | 
| Aurobindo Pharma | 661.47B |